Skip to main
LYEL
LYEL logo

Lyell Immunopharma (LYEL)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Lyell Immunopharma (LYEL) Stock

About Lyell Immunopharma (LYEL)

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
Market cap$144.23M
Today's volume80.52K
Revenue (TTM)$65K
Avg. daily volume98.77K
EBITDA (TTM)-$207.19M
Open$9.40
Price / earnings ratio-0.39x
Today's range$9.16 - $10.29
Debt / equity16.96x
52 week range$7.65 - $47
5 year debt / equity-65.25x
Beta (LTM)1.29x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio7.49x
Ex-dividend date
Next earningsAug 6, 2025
Dividend payable date

Lyell Immunopharma Stock Rating

What analysts recommend for LYEL stock, on a scale from 1(buy) to 5(sell).
Hold
Strong Buy 20%
Buy 0%
Hold 60%
Sell 20%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for LYEL stock is $144.24M

The current P/E ratio for LYEL stock is -0.39

The 52-week high for LYEL stock is $47. The current LYEL stock price $undefined is 100.00% below its 52-week high

The 52-week low for LYEL stock is $7.65. The current LYEL stock price $undefined has increased 100.00% from its 52-week low

No, the LYEL stock does not pay dividends to its shareholders

The target price for LYEL stock is $4.60 based on the average of what a group of analyst think LYEL stock could be worth at a future date. This is not a prediction by Public.com

How to buy LYEL stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in LYEL stock

    Navigate to the Explore page. Then, type LYEL into the search bar. When you see LYEL stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased LYEL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Lyell Immunopharma Stock Earnings

The value each LYEL share was expected to gain vs. the value that each LYEL share actually gained.

Lyell Immunopharma (LYEL) reported Q4 2024 earnings per share (EPS) of -$0.16, missing estimates of -$0.13 by 23.08%. In the same quarter last year, Lyell Immunopharma's earnings per share (EPS) was -$0.17. Lyell Immunopharma is expected to release next earnings on 08/06/2025, with an earnings per share (EPS) estimate of $0.

Buy Lyell Immunopharma (LYEL) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.